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A B S T R A C T
In the present review we analyze some clinical aspects of arrhythmias and their rela-
tionships with physical exercise; specific recommendations for exercise prescription in 
various arrhythmias and in arhythmogenic heart diseases, as well as the interactions 
between physical activity and antiarrhythmic therapies.
I N T R O D U C T I O N
Epidemiological, clinical and laboratory studies have yielded definitive evidence 
that physical activity is able to reduce the morbidity and mortality of cardiovascular 
diseases and to improve physical fitness and quality of life. Moreover, physical activ-
ity seems to be capable of significantly reducing the risk of developing other chronic 
diseases, such as obesity, osteoporosis, diabetes, some neoplasms and depression. 
For these reasons, physical exercise has been proposed as an efficacious, low-cost, 
physiological means of disease prevention and therapy. However, although enormous 
amounts of scientific data have demonstrated the benefits of a physically active lifestyle, 
only a minority of people in Europe take regular physical exercise. One of the prime 
objectives of healthcare institutions is therefore to promote physical activity in the 
general population, as well as in patients with cardiovascular diseases.
In the present review, we analyze the following points: some clinical aspects of 
arrhythmias and their relationships with physical exercise; the specific recommenda-
tions for exercise prescription in the various arrhythmias and in arhythmogenic heart 
diseases; the interactions between physical activity and antiarrhythmic therapies.
C l I N I C A l  A S p e C T S  O f  A R R h y T h m I A S
D I A g N O S T I C  A N D  p R O g N O S T I C  I N v e S T I g A T I O N  
O f  pA T I e N T S  w I T h  A R R h y T h m I A S
Many cardiac arrhythmias are clinically well tolerated; others depress pump func-
tion to varying degrees, and some can lead to sudden death. Sudden death is normally 
linked to an acquired or congenital heart disease. In the arrhythmic subject therefore, 
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the presence and type of any underlying heart disease should 
first of all be evaluated. 1-5
During clinical history, it is important to check for the 
presence of a family history of sudden death or genetic heart 
disease, arrhythmia-related symptoms (especially syncope) 
and possible triggering factors (e.g. hyperthyroidism). With 
regard to instrumental investigations, 12-lead ECG is crucial; 
indeed, in addition to yielding diagnostic information on single 
arrhythmias, in many cases it enables most potentially arrhyth-
mic heart diseases to be discovered, or at least suspected. Fur-
ther investigations may be prescribed when an organic heart 
disease is suspected (echocardiography), when the circadian 
pattern and the response of individual arrhythmias to effort 
need to be assessed (Holter monitoring, exercise testing), or 
when the mechanism of the arrhythmia itself is to be analyzed 
(electrophysiological study).
R e l A T I O N S h I p S  B e T w e e N  A R R h y T h m I A S  A N D 
p h y S I C A l  e x e R C I S e
Generally, physical exercise does not induce direct favour-
able effects on arrhythmic burden of patients with arrhythmias. 
Indeed, by increasing sympathetic activity, physical effort tends 
to favour the onset of both ventricular and supraventricular 
tachycardias. Moreover, increased sympathetic tone reduces 
the threshold of ventricular fibrillation. Finally, in pathological 
conditions, effort can induce arrhythmias indirectly through 
mechanisms such as ischemia, left ventricular outflow obstruc-
tion, etc. However, because of the above mentioned capacity to 
reduce total and cardiovascular morbidity and mortality, and to 
improve physical fitness and quality of life, judicious physical 
activity must be precribed also in patients with arrhythmias.
In the absence of heart disease, most arrhythmias are well 
tolerated from the hemodynamic point of view, even during 
effort. In the presence of heart disease, however, and obvi-
ously in relation to the type and degree of the disease, many 
arrhythmias can compromise pump function and even cause 
cardiac arrest.
Some heart diseases are particularly vulnerable to the 
development of malignant ventricular arrhythmias during 
effort: hypertrophic cardiomyopathy, arrhythmogenic right 
ventricular cardiomyopathy, coronary heart disease (includ-
ing congenital coronary anomalies) and myocarditis. Some 
ion channel disorders (long-QT syndrome, catecholaminergic 
polymorphic ventricular tachycardia) can be added to these 
disorders.5 Some physical activities may arouse a strong emo-
tional response (e.g. downhill skiing, climbing, etc); these are 
therefore to be avoided in all those arrhythmogenic conditions 
that are favoured by a sudden increase in catecholamines (e.g. 
long-QT syndrome). Finally, in sinus bradycardias and nodal 
atrio-ventricular blocks, regular high-intensity aerobic activity 
may have a worsening effect.
In those arrhythmias and potentially arrhythmogenic 
syndromes that are associated with a risk of syncope, any 
physical activity in which loss of consciousness may lead to 
death by injury or drowning (“intrinsic risk” activities), such 
as climbing, motorcycle sports, swimming, sub-water diving, 
etc., must be avoided.
R e C O m m e N D A T I O N S  
I N  T h e  v A R I O U S  A R R h y T h m I A S  
A N D  I N  A R R h y T h m O g e N I C  D I S e A S e S
The specific recommendations in the various arrhythmias 
and in potentially arrhythmogenic genetic heart diseases are 
summarized in Tables 1 and 2.
I N T e R R A C T I O N S  B e T w e e N  e x e R C I S e 
A N D  A N T I A R R h y T h m I C  T h e R A p I e S
A N T I A R R h y T h m I C  p h A R m A C O l O g I C A l 
T h e R A p y
Many subjects with arrhythmias take anti-arrhythmic drugs, 
most of which can have both cardiac and extra-cardiac side-
effects. In prescribing physical activity, it should be borne in 
mind that some drugs tend to depress myocardial contractil-
ity to varying degrees (e.g. class IC); while their effect is not 
significant in non-cardiopathic subjects, it may be considerable 
in patients with depressed left ventricular pump function. 
Moreover, other drugs reduce cardiac output, thereby reducing 
the chronotropic response to effort (e.g. beta-blockers), and 
others are banned by the International Olympic Committee 
as doping agents (e.g. beta-blockers, diuretics).
T R A N S C A T h e T e R  A B l A T I O N
Transcatheter alation is widely used in clinical practice to 
treat tachyarrhythmias. This procedure creates one or more 
coagulative lesions in the myocardium which tend to heal 
within a few days. There is no evidence to suggest that ablation 
has major arrhythmogenic effects. The treated arrhythmia may 
recur if the lesion is insufficient and its efficacy only transitory, 
though in general this will come to light within a few hours or 
a few days. After an efficacious ablation procedure, patients 
can undertake physical activity compatible with their state of 
health within a fairly short time (one month), as long as they 
suffer no symptomatic or electrocardiographic recurrence (e.g. 
reappearance of the delta wave in the Wolff-Parkinson-White 
syndrome). In asymptomatic subjects, follow-up electrophysi-
ological study is not normally necessary, with the exception of 
particular cases.
Patients who undergo ablation for atrial fibrillation (pul-
monary vein isolation, etc) or for atrial flutter, often suffer 
early recurrences, which may be asymptomatic. Moreover, 
many of these patients have to remain on anticoagulant 
therapy for long periods. An adequate observation period is 
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TABle 1. Recommendations for exercise prescription in individual arrhythmias
Arrhythmia
evaluations 
Recommended Clinical Situations Recommendations
Severe sinus 
bradycardia  
(<40 bpm) and/or 
pause >3 sec.
ET, Holter, consider 
Echo
a) asymptomatic, non-cardiopathic
b) asymptomatic after de-training
c) symptomatic
a) any activity
b) low-intensity activity without intrinsic 
risk
c) pacemaker implantation
Second-degree AVB, 
type 2, and third-
degree AVB
ET, Echo, Holter, 
consider
EPS
a) asymptomatic, non-cardiopathic,  
sporadic nodal AVB
b) symptomatic, cardiopathic,  
persistent subnodal AVB
a) any activity
b) pacemaker
Frequent 
supraventricular 
premature beats
Holter, Echo, 
consider ET
a) asymptomatic, non-cardiopathic
b) cardiopathic
a) any activity
b) individual decision
Ventricular premature 
beats
Holter, Echo, ET a) asymptomatic, non-cardiopathic
b) cardiopathic, frequent/ repetitive forms
a) any activity, if repetitive forms, 
individual decision
b) low-moderate intensity activity
Persistent or 
paroxysmal atrial 
fibrillation and flutter
Holter, Echo, ET a) asymptomatic, non-cardiopathic,  
heart rate not elevated on effort
b) symptomatic, cardiopathic
c) subjects on anticoagulant therapy
a) any activity
b) low-moderate intensity activities 
without intrinsic risk
c) avoid activities at risk of injury
Permanent atrial 
fibrillation and flutter
Holter, Echo, ET a) asymptomatic, non-cardiopathic,  
heart rate not elevated on effort
b) symptomatic and cardiopathic
c) subjects on anticoagulant therapy
a) low-moderate intensity activities
b) low intensity activities without intrinsic 
risk
c) avoid activities at risk of injury; consider 
ablation, particularly in cases of flutter
Supraventricular 
tachycardias without 
pre-excitation
Echo, Holter, ET 
(consider EPS)
a) sporadic forms, of brief duration, not related 
to effort, without syncope or heart disease
b) all other cases
a) any activity, excluding those with 
intrinsic risk; consider ablation
b) mild intensity activities; consider 
ablation
WPW syndrome Echo, ET, Holter 
(consider EPS)
a) asymptomatic, non-cardiopathic
b) symptomatic for reciprocating tachycardias
c) symptomatic for atrial fibrillation
a) mild intensity activities; for moderate-
high intensity activities EPS
b) EPS: if at risk, no activity or ablation
c) no activity; suggest ablation
Non-sustained 
ventricular  
tachycardia
Echo, Holter, ET; 
consider coronary 
angiography
a) no family history of sudden death, 
asymptomatic, non-cardiopathic, typical 
outflow tract or fascicular forms
b) symptomatic, cardiopathic
a) mild-moderate intensity activities; 
consider ablation
b) mild intensity activities
Sustained ventricular 
tachycardias
Echo, Holter, ET; 
consider coronary 
angiography 
a) no family history of sudden death, 
asymptomatic, non-cardiopathic, typical 
outflow tract or fascicular forms
b) symptomatic, cardiopathic
a) mild-moderate intensity activities; 
consider ablation
b) mild intensity activities; consider 
ablation
AVB= atrio-ventricular block; Echo = echocardiography; ET = exercise test; EPS = electophysiological study; WPW = Wolff-Parkinson-White 
(syndrome)
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TABle 2. Recommendations for exercise prescription in arrhythmogenic genetic diseases
Syndrome evaluations 
Recommended
Clinical Situations Recommendations
Long-QT syndrome (QTc 
>450 ms in males and 
>470 ms in females)
Holter, Echo, ET a) asymptomatic, carrier of the 
genetic defect with negative 
phenotype
b) symptomatic
a) mild intensity activities; avoid sudden effort 
and activities with intrinsic risk. Consider ICD 
for high-risk subjects (QTc >600 ms, etc)
b) mild intensity activities
Short-QT syndrome 
(QTc<320 ms) 
Holter, Echo, ET a) asymptomatic, no family history  
of sudden death
b) family history of sudden death, 
symptomatic
a) mild intensity activities. Consider ICD for 
carriers of the genetic defect and in the positive 
phenotype
b) No activity; consider ICD 
Brugada’s syndrome Holter, Echo,
ET; consider EPS
a) asymptomatic, low-risk
b) asymptomatic, high-risk
c) symptomatic
a) mild intensity activities
b) mild intensity activities; consider ICD
c) Consider ICD
Arrhythmogenic 
right ventricular 
cardiomyopathy 
Holter, Echo, ET a) asymptomatic without arrhythmias
b) asymptomatic with  
non-repetitive arrhythmias
c) symptomatic
a) mild-moderate intensity activities
b) mild intensity activities; avoid aerobic activities
c) Consider ICD
Catecholaminergic 
polymorphic ventricular 
tachycardia
Holter, Echo, ET In all cases  Mild intensity activities
Consider ICD
Hypertrophic 
cardiomyopathy
Holter, Echo, ET a) asymptomatic, low-risk
b) symptomatic and/or high-risk
a) mild intensity activities
b) mild intensity activities; consider ICD
Echo = echocardiography; ET = exercise test; ICD = implantable cardioverter defibrillator
therefore necessary before any type of physical exercise can 
be prescribed.
pA C e m A K e R S  ( p m )
Patients who have a PM may or may not be affected by 
structural heart diseases and by various arrhythmias. The type 
of physical activity that can be undertaken will depend on these 
differing circumstances.1-4 The following recommendations 
apply to these patients:
 a. In the first 6 months after implantation, the patient should 
avoid vigorous exercise and extreme movements of the 
ipsilateral limb, in order to avoid lead dislodgement;
 b. Activities involving physical contact or high intrinsic risk, 
and those performed in high-pressure environments (e.g. 
sub-water diving), are to be avoided, as these may damage 
the stimulator and/or the pacing leads. These precautions 
are particularly important if the patient is pacer-depend-
ent;
 c. Correct adjustment of the heart rate during effort should 
be assessed (by means of exercise testing and/or Holter 
monitoring). In this regard, it should be pointed out that, 
in sinus node disease, heart rate adjustment during effort 
is enabled by the AAI-R and DDD-R stimulation modes; 
in complete AV block (AVB), by the DDD and VDD 
modes; and in chronic atrial fibrillation, by the VVI-R 
mode. Given the different features of the sensors utilized 
in rate-responsive PM, evaluation must be made on a case-
by-case basis;
 d. Since right ventricular stimulation can, in time, worsen 
left ventricular pump function and/or accentuate mitral 
regurgitation, these parameters should be checked periodi-
cally.
I m p l A N T A B l e  C A R D I O v e R T e R 
D e f I B R I l l A T O R  ( I C D )
A patient with an ICD may have a structurally normal heart 
or be affected by organic diseases that do not significantly 
compromise left ventricular pump function. Many patients, 
especially if young, should not be precluded from an active 
life, or even from sport, simply because they have an ICD. 
Moreover, even patients with structural heart disease can 
benefit from physical exercise.1-4
In ICD patients, in addition to the recommendations ap-
plicable to PM patients, the following considerations should 
40
HOSPITAL CHRONICLES 4(1), 2009
be made:
 a. patients who have already suffered from ventricular tachy-
cardias or ventricular fibrillation should not undertake 
demanding physical activity for at least six months after 
the last appropriate ICD intervention;
 b. it should be borne in mind that sinus tachycardia may cause 
inappropriate shocks, as the ICD may interpret the sinus 
tachycardia as ventricular tachycardia if it exceeds the pro-
grammed cut-off rate. To obviate this risk, the ICD should 
be a dual-chamber model (which discriminates better 
between the two situations); the discrimination algorithms 
should be active; the programmed cut-off rate should be 
high (if possible, above the patient’s maximum heart rate); 
and the use of beta-blockers should be considered. In addi-
tion, patients should be made aware of the problem so that 
they can check their own heart rate during effort. Given 
the wide variability among individual patients, evaluation 
(by means of exercise testing and/or Holter monitoring) 
should be made on a case-by-case basis;
 c. in spite of the protection provided by the ICD, activities 
that can trigger malignant arrhythmias are to be avoid-
ed.
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